CDC-Recommended Rapid Diagnostic Tests for Dengue
The CDC recommends a combination approach using nucleic acid amplification tests (NAATs) and NS1 antigen detection for specimens collected ≤7 days after symptom onset, followed by IgM/IgG antibody testing for specimens collected >7 days post-symptom onset, with confirmatory plaque reduction neutralization tests (PRNTs) when needed. 1
Available Rapid Diagnostic Test Types
The CDC guidelines recognize three main categories of rapid diagnostic tests for dengue:
1. NS1 Antigen Detection Tests
- Timing: Most effective during the first 7 days of illness, particularly days 3-4 post-symptom onset 1
- FDA-cleared option: Enzyme immunoassay detecting dengue virus NS1 antigen in serum 1
- Performance: Sensitivity ranges from 49-59% with specificity of 93-99% in field studies 2
- Specimen types: Serum, plasma, or whole blood 1
2. IgM/IgG Antibody Detection Tests
- Timing: Optimal for specimens collected >7 days after symptom onset 1
- FDA-cleared option: Enzyme immunoassay detecting dengue virus IgM antibodies in serum 1
- Performance: IgM sensitivity ranges from 71-80% with specificity of 46-90% 2
- Important caveat: IgM antibodies can persist for months to years after infection, making timing of infection difficult to determine 1
3. Combination NS1/IgM/IgG Tests
- Best overall performance: Combining NS1 antigen and IgM antibody detection achieves 93% sensitivity and 89% specificity 2
- Examples: SD Bioline Dengue Duo (NS1 Ag and IgG/IgM) with overall sensitivity of 87.3% and specificity of 86.8% during first 14 days 3
CDC Testing Algorithm
For Specimens Collected ≤7 Days Post-Symptom Onset:
Step 1: Perform dengue NAAT (or NS1 antigen test as alternative) 1
- If positive: Confirms acute dengue infection; perform PRNTs if epidemiologically significant
- If negative: Proceed to IgM/IgG antibody testing
Step 2: If NAAT negative, perform IgM antibody testing 1
- Important: Negative results <7 days may reflect collection before antibody development and does not rule out infection 1
For Specimens Collected >7 Days Post-Symptom Onset:
Step 1: Perform IgM and IgG antibody testing 1
- If positive: Proceed to confirmatory PRNTs when definitive diagnosis needed
- If negative: Rules out recent dengue infection; consider other etiologies 1
Step 2: Confirmatory PRNT testing 1
- PRNT titer ≥10 against dengue with <10 against Zika/other flaviviruses = recent dengue infection
- PRNT titer ≥10 for both dengue and Zika = flavivirus infection but cannot distinguish specific virus
Critical Performance Considerations
Timing-Dependent Sensitivity:
- NS1 detection: Highest sensitivity days 3-4 post-symptom onset, declining after day 7 4
- IgM detection: Develops during first week, peaks at 2-4 weeks, can persist for months 1
- Combined NS1 + IgM: Provides best sensitivity across all time points 2
Serotype Variations:
- Most tests show lower sensitivity for DENV-4 compared to other serotypes 4
- Secondary infections may have reduced sensitivity due to diminished IgM response 1
Cross-Reactivity Issues:
- Major pitfall: False-positive IgM results occur due to cross-reactivity with other flaviviruses (West Nile, Zika, yellow fever, Japanese encephalitis) 1
- Solution: Confirmatory PRNTs required when definitive diagnosis needed for clinical or epidemiologic purposes 1
Practical Implementation
For early presentation (days 1-7): Use combination NS1/IgM rapid tests, with NS1 component providing primary diagnostic value 2
For late presentation (>7 days): IgM/IgG antibody tests become primary diagnostic tool, but require PRNT confirmation for definitive diagnosis 1
For pregnant women: CDC recommends concurrent NAAT and IgM testing on serum plus NAAT on urine, collected within 12 weeks of symptom onset 1
Common Pitfalls to Avoid
Do not rely on single IgM result alone - requires PRNT confirmation due to high false-positive rate from cross-reactivity 1
Do not rule out dengue with negative test <7 days - may reflect pre-antibody development period 1
Do not assume timing of infection from IgM positivity - antibodies persist for months, making recent vs. past infection difficult to distinguish 1
Do not use NS1 tests alone after day 7 - sensitivity drops significantly; switch to antibody-based testing 1